Prosecution Insights
Last updated: May 29, 2026

Kymera Therapeutics Inc.

7 pending office actions • 4 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 13 patents granted in the last 365 days

Portfolio Summary

7
Total Pending OAs
6
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

7
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (7)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
3
Medium (43%)
4
Easy (57%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (29%)
§102 only1 (14%)
§112 only4 (57%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

7
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

70 h
Manual time on pending OAs
14 h
Time saved (low, 20%)
24 h
Time saved (mid, 35%)
0.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
VAJDA, KRISTIN ANN 1 84.1% +10.6%
ABDALHAMEED, MANAHIL MIRGHANI ALI 1 50.4% +41.3%
ISMAIL, REHANA 1 78.9% +30.2%
SEITZ, ANTHONY JOSEPH 1 68.8% +28.3%
BRAUN, MADELINE E 1 68.0% +24.9%
MCANANY, JOHN D 1 68.0% +51.2%
BURKETT, DANIEL JOHN 1 65.4% +24.5%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18759253 CDK2 DEGRADERS AND USES THEREOF VAJDA, KRISTIN ANN 89d overdue

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
17597166 IRAK DEGRADERS AND USES THEREOF BURKETT, DANIEL JOHN 164d overdue
18486889 SALT FORMS OF IRAK4 DEGRADERS ISMAIL, REHANA 132d overdue
18030865 STAT DEGRADERS AND USES THEREOF MCANANY, JOHN D 99d overdue
18759253 CDK2 DEGRADERS AND USES THEREOF VAJDA, KRISTIN ANN 89d overdue
18559492 DEUTERATED IRAK DEGRADERS AND USES THEREOF ABDALHAMEED, MANAHIL MIRGHANI ALI 32d overdue
18453163 CDK2 INHIBITORS AND USES THEREOF SEITZ, ANTHONY JOSEPH 8d overdue
18547038 SMARCA DEGRADERS AND USES THEREOF BRAUN, MADELINE E 8d overdue

Top Art Units

Art UnitApps
1622 2
1625 2
1624 2
1629 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18759253 CDK2 DEGRADERS AND USES THEREOF VAJDA, KRISTIN ANN 1622 §112 Non-Final OA 89d overdue Pending Jun 28, 2024
18559492 DEUTERATED IRAK DEGRADERS AND USES THEREOF ABDALHAMEED, MANAHIL MIRGHANI ALI 1622 §103 Non-Final OA 32d overdue Pending Nov 07, 2023
18486889 SALT FORMS OF IRAK4 DEGRADERS ISMAIL, REHANA 1625 §112 Non-Final OA 132d overdue Pending Oct 13, 2023
18453163 CDK2 INHIBITORS AND USES THEREOF SEITZ, ANTHONY JOSEPH 1629 §102 Non-Final OA 8d overdue Pending Aug 21, 2023
18547038 SMARCA DEGRADERS AND USES THEREOF BRAUN, MADELINE E 1624 §112 Non-Final OA 8d overdue Pending Aug 18, 2023
18030865 STAT DEGRADERS AND USES THEREOF MCANANY, JOHN D 1625 §112 Non-Final OA 99d overdue Pending Apr 07, 2023
17597166 IRAK DEGRADERS AND USES THEREOF BURKETT, DANIEL JOHN 1624 §103 Final Rejection 164d overdue Pending Dec 28, 2021

Managing Kymera Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month